Altasciences Clinical Los Angeles, Inc
Cypress, California, United States
Research institute in Cypress, California
5630 W Cerritos Ave, Cypress, CA 90630
About Altasciences Clinical Los Angeles, Inc
"Altasciences LA is a full-service CRO offering clinical development services to the pharmaceutical, biotechnology, and medical device industries. As a drug development partner, Altasciences LA collaborates with domestic and foreign innovator companies who need regulatory, program management, and strategic consulting support."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
9
Cidara Therapeutics Inc.
1
Clinical Trials at Altasciences Clinical Los Angeles, Inc
During the past decade, Altasciences Clinical Los Angeles, Inc conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants
2020-07-07
2024-06-30
Recruiting
224
A Safety Study of LY3462817 in Healthy Japanese and Non-Japanese Participants
2022-06-28
2023-03-08
Completed
33
A Study of Imlunestrant (LY3484356) in Female Healthy Participants
2022-07-07
2022-11-02
Completed
113
A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants
2022-08-31
2023-02-20
Completed
396
A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia
2022-11-14
2024-08-07
Recruiting
120
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Altasciences Clinical Los Angeles, Inc"
#1 collaborator was "Janssen Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Altasciences Clinical Los Angeles, Inc
According to Clinical.Site data, the most researched conditions in "Altasciences Clinical Los Angeles, Inc" are
"Healthy" (8 trials), "Alzheimer Disease" (1 trials), "Dyslipidemias" (1 trials) and "Hypertriglyceridemia" (1 trials). Many other conditions were trialed in "Altasciences Clinical Los Angeles, Inc" in a lesser frequency.
Clinical Trials Intervention Types at Altasciences Clinical Los Angeles, Inc
Most popular intervention types in "Altasciences Clinical Los Angeles, Inc" are "Drug" (10 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Mirikizumab" (2 trials), "CD388 Injection" (1 trials), "Dextromethorphan" (1 trials) and "Digoxin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Altasciences Clinical Los Angeles, Inc
The vast majority of trials in "Altasciences Clinical Los Angeles, Inc" are
9 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Altasciences Clinical Los Angeles, Inc
Currently, there are NaN active trials in "Altasciences Clinical Los Angeles, Inc".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Altasciences Clinical Los Angeles, Inc,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Altasciences Clinical Los Angeles, Inc, 10 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".